As China nears peak aluminium production, what next?: Andy Home
LONDON - China's aluminum production juggernaut is finally running out of road as the country's output approaches the government's capacity limit.
Massive investment in primary metal smelting capacity has lifted Chinese production to 43 million in 2024, or 60% of globlal output, from just four million metric tons in 2004.
Its growing dominance of the global aluminium supply chain has met increasing resistance from Western countries, initially in the form of trade complaints and anti-dumping duties and more recently in the form of U.S. tariffs.
None of which has stemmed China's exports of semi-fabricated aluminium products, which jumped by 19% to hit a record 6.2 million tons last year.
But things are about to change.
Beijing's aluminium "Action Plan" for 2025-2027 confirms the capacity cap remains in place and sets out a strategy for what happens next.
TOUCHING THE CEILING
China's primary aluminium production grew by 2.6% year-on-year in the first quarter of 2025, according to the International Aluminium Institute.
Annualised production averaged 44 million tons over January-March, just a million tons short of the 45-million ton cap, which was set in 2017.
It is technically possible for the country's production to exceed the cap, according to consultancy AZ Global.
Smelter capacity is rated by designed amperage for the electrolysis production process but "one of the first jobs of any plant manager is to push output to above the rate," it says. Nudging the amperage higher allows a smelter to produce over its nameplate capacity.
But AZ China estimates that capacity utilisation in China is already very high at 98.2%, leaving little room for further collective amperage creep.
It is also clear that China's production growth is starting to slow from the average 4.0% annual rate seen over the last five years.
GOING GREEN
Chinese operators are still building new smelters, but the new capacity must be offset by closures of older capacity.
Indeed, Beijing's policies for the sector are focused on eliminating less efficient capacity and ensuring newer smelters are powered by renewable energy resources.
Aluminium producers are migrating from coal-rich provinces to new energy hubs, such as Yunnan with its abundant hydro power and Inner Mongolia, which has massive wind and solar potential.
The aim is to produce more low-carbon metal and the action plan calls for renewable energy to account for 30% of national smelter power demand by 2027.
To offset slow to no growth in primary production, Beijing is seeking to stimulate production from scrap with a recycling target of over 15 million tons per year in 2027.
REDUCED EXPORTS
Another offset has already kicked in.
The government removed tax rebate subsidies of 13% on exports of aluminium products in December in a move clearly intended to keep more metal in the domestic market.
Exports have since slowed sharply with outbound volumes down by 11% year-on-year in January and February.
Analysts at Macquarie Bank forecast exports to fall by 8% over 2025 with any sharper collapse unlikely since the world outside of China is heavily dependent on its products to the tune of around 15% of total demand.
Some Western buyers will in all likelihood at least partly accept the higher cost.
But the chances are that Chinese aluminium exports may have peaked.
REPRIEVE FOR WESTERN PRODUCERS?
The combination of slowing Chinese domestic production growth and reduced export flows opens a window of opportunity for the rest of the world's primary aluminium producers.
The United States has nearly a million tons of idled smelting capacity. U.S. President Donald Trump's 25% import tariffs on aluminium are intended to stimulate restarts.
Europe too has around half of its primary smelting capacity out of action after the power price surge that followed Russia's invasion of Ukraine in 2022.
The structural changes being implemented by the world's largest producer may offer such plants a reprieve, although restarting idled capacity is also a question of both aluminium and power prices.
There is, however, renewed interest in building greenfield smelters in the West after years of low investment.
U.S. producer Century Aluminum has received $500 million in government funds for a project to launch the first new smelter in the United States in 45 years.
Rio Tinto is studying low-carbon smelter projects in both Finland and India.
BUT CHINESE DOMINANCE WILL REMAIN
However, Chinese producers are also going overseas due to the lack of domestic expansion potential.
Indeed, Beijing's aluminium action plan calls for deeper cooperation with resource-rich nations such as Guinea, where China's Chinalco is part of a project to convert the country's bauxite resources into alumina.
In Indonesia, Shandong Nanshan Aluminium is already producing alumina and plans to expand its refining capacity and to add a 260,000-ton-per year smelter.
China may have stopped building domestic capacity but evidently has no intention of loosening its grip on a metal that the United States and the European Union both classify as a critical raw material.
The opinions expressed here are those of the author, a columnist for Reuters.
(Editing by Barbara Lewis)

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Arabian Post
25 minutes ago
- Arabian Post
MediLink Therapeutics Taps Major Banks for Hong Kong Float
MediLink Therapeutics Ltd. is preparing to launch an initial public offering in Hong Kong, having secured China International Capital Corp., JPMorgan Chase & Co. and Morgan Stanley as its lead advisers, according to people with knowledge of the matter. The move comes as the clinical-stage biotech firm seeks to capitalise on growing investor interest in advanced tumour-targeting therapies and consolidate its platform of antibody‑drug conjugates. Founded in 2020 and headquartered in Suzhou with R&D operations in Shanghai and Boston, MediLink has developed a proprietary ADC technology known as TMALIN®. The platform facilitates precise delivery of cytotoxic agents to tumour cells, with the intention of widening therapeutic windows for solid tumour treatments. Its pipeline includes programs that have advanced to clinical stages in both China and the United States, supported by a Series B financing round of approximately USD 70 million in 2022. MediLink's strategic engagement of three underwriters reflects heightened confidence in anchor investors and broader syndication. China International Capital Corp. brings deep roots in Chinese capital markets and extensive IPO experience in the biotech sector. JPMorgan and Morgan Stanley add global banking heft and access to international investors. ADVERTISEMENT CICC itself is emerging as a top-tier sponsor for Hong Kong listings. It led or co-led 19 IPOs for Chinese corporates last year, raising USD 3.84 billion, positioning it as a dominant force amid market revival. The engagement of internationally renowned banks alongside CICC is likely aimed at boosting MediLink's valuation and widening investor interest both locally and abroad. While IPO details remain confidential, analysts suggest MediLink could seek a valuation in the mid‑to‑high hundreds of millions of dollars. That would reflect both the advanced stage of its pipeline and prevailing market multiples for ADC developers. Comparable biotech flotations in Hong Kong and the U.S. have reflected growing appetite for oncology-focused platforms. Alongside listing ambitions, MediLink continues to advance its clinical and licensing goals. In March it unveiled preclinical data at the American Association for Cancer Research annual meeting; earlier in the year it received FDA clearance for its IND application for YL217, its lead candidate. YL201, another programme, received Breakthrough Therapy Designation in January for treatment of recurrent/metastatic nasopharyngeal carcinoma. The company has also pursued strategic licensing agreements with global pharmaceutical firms to expand development and commercialisation capabilities. A licensing deal under discussion ahead of the IPO is believed aimed at enhancing distribution reach while reinforcing MediLink's balance sheet. The IPO effort is part of a broader resurgence in biotech listings in Hong Kong, where authorities have eased regulations to attract innovation-driven offerings. CICC and other banks have ramped up support for ADC and gene therapy companies, signalling a turning point after a lull in listings. ADVERTISEMENT MediLink's choice of banks aligns with a wider trend: CICC has co-sponsored blockbuster floats including the forthcoming mega‑IPO of CATL, while banks like Goldman Sachs and Morgan Stanley have also participated. In this context, MediLink is positioning itself to tap both deep domestic networks and international capital. Stakeholder sentiment appears optimistic. MediLink's management team, comprised of co‑founders Tony Xue and Jiaqiang Cai alongside C‑suite leaders experienced in drug development and financial strategy, has overseen steady progress in its ADC pipeline and established global partnerships. Jason Li's appointment as CFO in 2023 reportedly strengthened the company's capital market readiness. Market observers highlight challenges ahead. ADC development remains capital-intensive, clinical risks high, and competition fierce among domestic and international peers. Success will hinge on late‑stage data and licensing traction. At the same time, geopolitical tensions and volatility in Hong Kong equity markets may affect investor sentiment. MediLink must also navigate post‑IPO obligations, including regulatory reporting and corporate governance under Hong Kong's Main Board requirements. Mitigating execution risk will be critical, underscoring the role of its chosen bankers in underwriting diligence and market support. Analysts describe the listing as a pivotal moment: it offers the backing to fund Phase II/III efforts while elevating MediLink's corporate profile. For banks, it reinforces Hong Kong's appeal as a biotech capital market when compared with established centres like Nasdaq. With its IPO process underway, MediLink now awaits market timing and regulatory clearances before formally filing a prospectus. The company is expected to continue advancing clinical data, strengthening licensing ties, and preparing investor materials aligned with regulatory requirements.


Arabian Post
10 hours ago
- Arabian Post
Ethiopia Targets 8.9 % Growth as Budget Widens
Ethiopia's finance minister has announced that the economy is projected to expand by 8.9 % in the fiscal year beginning 8 July 2025, alongside a modest increase in the budget deficit amid structural reforms. Finance Minister Ahmed Shide addressed parliament on Tuesday, outlining the forecast for the next fiscal year, citing an acceleration in real GDP growth from an estimated 8.4 % this year to 8.9 % next year. The state budget deficit is expected to rise slightly to 2.2 % of GDP, compared to 2.1 % in the current year. Total government expenditure is projected at 1.9 trillion birr, equivalent to around US $14 billion. This positive outlook is deeply anchored in ongoing reforms backed by an International Monetary Fund programme. These include the liberalisation of the exchange rate, debt restructuring negotiations, and the establishment of the Ethiopian Securities Exchange, which opened in January after a 50‑year absence. ADVERTISEMENT The cabinet's approval of the new budget earlier this month signalled a strategic reallocation of resources, with spending set to increase by 31 % compared to the previous year's 971 billion birr. A significant portion is earmarked for national security, productivity enhancement, and disaster relief, including continued subsidies for fuel, fertiliser, oil and medicines—a move aimed at dampening inflationary pressure on households. Reforms and their impacts The IMF programme that began in July 2024 has been a linchpin in the reform agenda. In April, State Finance Minister Eyob Tekalign reported that the third review of the four‑year US $3.4 billion loan arrangement had reached staff‑level agreement, with approval by the IMF executive board anticipated this month. Subsequent draws will hinge on continued reform progress, notably debt restructuring. Debt, inflation and exchange rate liberalisation remain pressing concerns. A draft budget revealed that 463 billion birr—nearly 39 % of recurrent expenditure—will go towards debt servicing, surpassing planned capital outlays. The government intends to restructure approximately US $3.5 billion in external liabilities through agreements in upcoming weeks. Bondholder writedowns are expected as part of a broader debt resolution strategy. Monetary reforms have lessened inflation, which reached 29.2 % in 2022/23, and narrowed the spread between official and parallel exchange rates. Foreign reserves have rebounded, tripling to US $3.6 billion, easing foreign exchange shortages. These financial indicators have been central in IMF assessments. Policy makers are awaiting formal debt restructuring talks this summer with official and private creditors alike, guided by the G20 Common Framework. Iran‑timed agreements with Chinese policy banks, the U.S. International Development Finance Corporation and other funders are being explored to support infrastructure and development needs. Regional comparisons and strategic outlook Ethiopia remains one of sub‑Saharan Africa's highest growth economies, although still below the pre‑covid annual average of around 10 %. The country's trajectory continues to be shaped by recovery from the Tigray war, covid‑19 disruptions, droughts and locust invasions, but ongoing reforms are expected to unlock further expansion. The imminent fiscal year budget, combining a steep rise in expenditure with a stabilising deficit, underscores a cautious but ambitious strategy: focusing on debt management, reform momentum and public service delivery, rather than unfettered spending. Key stakeholders, including opposition figures such as Desalegn Chane of the National Movement of Amhara, have voiced concern over rising tax burdens amid steady living costs and a depreciating birr. Criticism has targeted new levies on motor vehicles and excise taxes, with claims these conflict with subsidy policies. The finance minister, however, defended these as necessary for fiscal resilience and revenue expansion. Broader reform dynamics have been influenced by Prime Minister Abiy Ahmed's economic agenda, including the launch of Ethiopia's first stock market since the Haile Selassie era, currency liberalisation, and opening the banking sector to foreign investment. These steps have been deemed essential to securing up to US $27 billion in external funding from IMF, World Bank, UAE, China and others over the next four years. Looking ahead The projection of roughly 8.9 % GDP growth signals confidence that reforms are gaining traction, even as the government prepares to finance a wider budget and service rising debt. The success of the IMF programme's next review, debt restructuring outcomes, and reform implementation will determine whether Ethiopia can sustain its economic momentum and weather domestic and global headwinds.


Tourism Breaking News
18 hours ago
- Tourism Breaking News
China extends visa-free entry to four GCC countries
Post Views: 35 China has launched a trial policy granting unilateral visa-free entry to citizens of Saudi Arabia, Oman, Kuwait, and Bahrain, expanding its visa-free access list to 47 countries, as per the recent report. Effective until June 8, 2026, the policy allows ordinary passport holders from these four Gulf Cooperation Council (GCC) countries to enter China visa-free for up to 30 days for business, tourism, family visits, cultural exchange, and transit. The policy has been warmly received across the Gulf region and is expected to enhance bilateral exchanges, strengthen cultural and people-to-people ties, and drive broader cooperation between China and the GCC. Currently, around 20 direct flights operate weekly between key Chinese cities—including Beijing, Shanghai, Guangzhou, and Shenzhen—and Saudi cities like Riyadh and Jeddah. The UAE is connected to 13 cities across mainland China through direct flights. This expansion marks a significant step in building economic and cultural relations between China and the Gulf states.